Nelum Corp.
🇺🇸United States
Clinical Trials
1
Active:1
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Study to Evaluate the Safety and Efficacy of Treatment With NLM-001 and Standard Chemotherapy Plus Zalifrelimab in Patients With Advanced Pancreatic Cancer
Phase 1
Active, not recruiting
- Conditions
- Pancreatic Ductal Adenocarcinoma
- Interventions
- First Posted Date
- 2021-04-01
- Last Posted Date
- 2024-12-30
- Lead Sponsor
- Nelum Corp
- Target Recruit Count
- 28
- Registration Number
- NCT04827953
- Locations
- 🇪🇸
Hospital Clínico Universitario de Santiago, Santiago De Compostela, A Coruña, Spain
🇪🇸Hospital Universitario Virgen De La Victoria, Málaga, Andalucía, Spain
🇪🇸Hospital Universitario Miguel Servet, Zaragoza, Aragón, Spain
News
No news found